Novartis is laying off a total of 139 staffers in East Hanover, New Jersey, where the company’s U.S. headquarters is located, according to a pair of Worker Adjustment and Retraining Notification (WARN) alerts filed (PDF) in the Garden State this month.
Novartis confirmed the staff reductions via email, with a company spokesperson noting that the moves will primarily affect commercial field sales associates working on the brands Xolair, for asthma and allergies, and the oncology combo made up of kinase inhibitors Tafinlar and Mekinist (Taf+Mek).
https://www.fiercepharma.com/pharma/novartis-plots-more-100-layoffs-new-jersey-part-rework-xolair-tafmek-field-teams-ahead-new